Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle

NCT03267264 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
248
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Becton, Dickinson and Company